Home›Companies›Healthcare›CardioNexa

CardioNexa, Inc.

Managed cholesterol treatment services for cardiology practices.

Updated Nov 10, 2026·Latest SEC filing Mar 30, 2026·Suggest an edit

About CardioNexa

CardioNexa is a private company based in Newton, Massachusetts, incorporated in 2026 in Delaware. It has reported $300,000 raised in one offering on Form D since March 2026. Its chief executive is Stanley Tam.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 14, 2026Mar 30, 2026$300,000fully sold2$150KEquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on CardioNexa's Form D filed Mar 30, 2026.

AT
Anli Tam
COO, CTO & Co-Founder, director
ST
Stanley Tam
CEO, CMO & Co-Founder, director

Sources

  1. SECCardioNexa, Inc. filing history
  2. CompanyCardioNexa privacy policy